Anilazine: Target Organs and Levels of Evidence for TR-104
Bioassay of Anilazine for Possible Carcinogenicity (CASRN 101-05-3)
| Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
|---|---|---|---|
| Anilazine 101-05-3 |
06/29/1978 | Dosed-Feed 0,500,1000 PPM |
Gulf South Research Institute |